Breast Imaging Market is Estimated To Witness High Growth Owing To Technological Advancements

The global Breast Imaging Market is estimated to be valued at US$ 3,905.2 million in 2022 and is expected to exhibit a CAGR of 7.6% over the forecast period 2022-2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Breast imaging is a medical procedure used to detect breast cancer and other abnormalities in the breasts. It involves the use of various imaging technologies such as mammography, ultrasound, and MRI to obtain detailed images of breast tissue. These images help in the early detection and diagnosis of breast cancer, leading to timely treatment and improved patient outcomes. The advantages of breast imaging include early detection of cancer, non-invasive procedure, and ability to detect abnormalities in dense breast tissue. With the increasing incidence of breast cancer and advancements in imaging technologies, the demand for breast imaging products is expected to rise significantly in the coming years.

Market key trends:

One key trend driving the growth of the breast imaging market is technological advancements. The field of breast imaging has witnessed significant advancements in recent years, leading to improved diagnostic accuracy and patient comfort. For instance, the development of digital mammography has revolutionized breast cancer screening by providing better image quality and reducing the radiation dose. Similarly, the introduction of 3D breast tomosynthesis has enhanced the detection of small breast lesions, improving the overall diagnostic accuracy. Moreover, the introduction of contrast-enhanced mammography and automated breast ultrasound systems has further improved the detection and characterization of breast abnormalities. These technological advancements are expected to drive the adoption of breast imaging products, leading to market growth in the forecast period.

PEST Analysis:

Political: The political factor for the breast imaging market is relatively stable, with the government regulatory bodies playing a crucial role in ensuring the safety and efficacy of breast imaging technologies.

Economic: The economic factor for the breast imaging market is favorable, with the market expected to witness high growth and reach a value of US$ 3,905.2 million in 2022. The increasing prevalence of breast cancer and the rising demand for early detection and diagnosis are driving the market growth.

Social: The social factor for the breast imaging market is characterized by the growing awareness among women about breast health and the importance of regular screenings. This has led to increased adoption of breast imaging technologies and has contributed to the market growth.

Technological: The technological factor for the breast imaging market is rapidly evolving, with advancements in imaging technologies and the development of innovative techniques. The integration of artificial intelligence and machine learning algorithms into breast imaging systems has improved the accuracy and efficiency of diagnoses.

Key Takeaways:

The global Breast Imaging Market Share  is expected to witness high growth, exhibiting a compound annual growth rate (CAGR) of 7.6% over the forecast period (2022-2030). The increasing prevalence of breast cancer, coupled with the rising awareness about early detection and diagnosis, is driving the market growth.

In terms of regional analysis, North America is the fastest-growing and dominating region in the breast imaging market. The region has a well-established healthcare infrastructure, higher healthcare spending, and a strong presence of key market players. Additionally, the high incidence of breast cancer in the region has contributed to the growth of the breast imaging market.

Key players operating in the breast imaging market include GE Healthcare, Siemens Healthcare GmbH, Seno Medical, Koninklijke Philips N.V., Fujifilm Holdings Corporation, Hologic, Inc., Aurora Imaging Technologies, Inc., Canon Inc., Dilon Technologies, Inc., Leica Biosystems Nussloch GmbH (Danaher), Carestream Health, Avante Health Solutions, Hitachi, Ltd, PLANMED OY, and Barco. These key players are involved in strategic initiatives such as mergers and acquisitions, product launches, and collaborations to strengthen their market position and expand their product offerings.

Read more @

Leave a Reply

© 2023 THEWION - WordPress Theme by WPEnjoy